Patients with hypertension and the GG genotype may have a decreased response to hydrochlorothiazide, as measured by an increase in systolic blood pressure, as compared to patients with the AA or AG genotypes. Other genetic and clinical factors may also affect a patient's response to hydrochlorothiazide.